Michael Greiner - 14 Mar 2024 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Signature
/s/ Mojirade James, as attorney-in-fact for Michael C. Greiner
Issuer symbol
AVNS
Transactions as of
14 Mar 2024
Transactions value $
-$152,980
Form type
4
Filing time
15 Mar 2024, 11:40:21 UTC
Previous filing
07 Mar 2024
Next filing
19 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Sale -$72.6K -3.8K -2.38% $19.11 156K 14 Mar 2024 Direct
transaction AVNS Common Stock Sale -$13.7K -714 -0.46% $19.12 155K 14 Mar 2024 Direct
transaction AVNS Common Stock Sale -$42.7K -2.23K -1.44% $19.13 153K 14 Mar 2024 Direct
transaction AVNS Common Stock Sale -$6.45K -337 -0.22% $19.14 152K 14 Mar 2024 Direct
transaction AVNS Common Stock Sale -$15.5K -808 -0.53% $19.15 152K 14 Mar 2024 Direct
transaction AVNS Common Stock Sale -$2.11K -110 -0.07% $19.16 151K 14 Mar 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

On January 2, 2023, March 4, 2023 and May 7, 2023, a total of 61,472 time-based restricted share units held by the Reporting Person vested (the Vested TRSUs). On March 14, 2024, the Reporting Person completed the sale of 8,000 shares of the Issuer's common stock. The Reporting Person has advised the Issuer that: (i) he intends to use the proceeds from the sale of such shares to satisfy the tax obligations resulting from the vesting of the Vested TRSUs and (ii) he was not in possession of material non-public information regarding the Issuer at the time of such sale.